In the treatment of bleeding peptic ulcers, the concept of dual therapy combining a second modality to epinephrine injection is theoretically appealing. The addition of a sclerosant has not been shown to be beneficial. Early evidence suggests that adding contact thermocoagulation or a thrombogenic agent improves patient outcome.
|Original language||English (US)|
|Number of pages||17|
|Journal||Gastrointestinal Endoscopy Clinics of North America|
|State||Published - 1997|
ASJC Scopus subject areas